Blog
Blog
Video
Blog
19 May, 2021 Author Morgan Frey
The pandemic-fueled popularity of online tools for primary and chronic care have emboldened investors to seek more specialized opportunities in digital health. Women s health may be their next target.
With patients pushed online by COVID-19, companies like Teladoc Health Inc. whose share price more than doubled in 2020 got a warm reception on Wall Street. That led to greater interest in digital tools aimed at treating a chronic care population with conditions like diabetes and heart disease.
The enthusiasm has not quite caught up with digital women s health, often dubbed femtech. The field includes companies focused on maternal care, fertility and gynecologic care and is expanding into areas such as menopausal care and female reproductive cancers.
Arab Health appoints experts from around the world
tradearabia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tradearabia.com Daily Mail and Mail on Sunday newspapers.
5 Strategic Insights Set to Power the Femtech Market
USA - English
Share this article
Share this article
In honor of International Women s Day, Frost & Sullivan experts share key findings on how femtech is improving women s health and empowering them globally
SANTA CLARA, Calif., March 8, 2021 /PRNewswire/ As we celebrate
International Women s Day and this year s theme
#ChooseToChallenge, Frost & Sullivan acknowledges the critical role of technology, such as artificial intelligence and big data analytics, in improving women s lives and empowering them.
5 Strategic Insights Set to Power the Femtech Market
Femtech (female technology) is an emerging term and is poorly understood, as is the case with most new concepts. While some relate femtech only with products unique to reproductive health (including consumer products), others dismiss it as just another term for a group of existing solutions. Our experts believe it is a unique space and a place for new growth opportun
Share
Now that 2020 has come to a close, many are taking time to reflect on the lessons learned from the challenging past year to create a new perspective going into the future.
The healthcare industry is no different, and several leaders in the space sat down this week at an Accelerate Health virtual panel to discuss what the pandemic taught them, how they’re adjusting for the road ahead and ways to make the changes stick.
“This pandemic really has been a turning point for all of us in healthcare,” Rasu Shrestha, the executive vice president and chief strategy officer at Atrium Health, said during the New Year s Resolutions: Shaping the Next Decade in Healthcare panel. “It’s really given us a level of intentionality never before seen in the modern history of our industry.”
07:05 AM
In the year 2020, the COVID-19 pandemic left many businesses in an unprecedented state of uncertainty. Healthcare companies across the care continuum had to face new challenges, pushing them to rapidly learn, adapt and transform the way they deliver healthcare. As a result, the concept of “anytime anywhere care” has become mainstream, changing the rate at which we access healthcare forever. Vendors will consequently need to redefine their strategies to ensure they are ready for 2021 and this new breed of consumer demand.
Opportunities to innovate
While the pandemic has presented many adversities, it has also introduced growth opportunities to enhance companies performance, leading to the acceleration of new customer engagement models and innovative methods to serve customer needs.
vimarsana © 2020. All Rights Reserved.